Advance your immuno-oncology research with Evotec’s humanized mouse models - designed to replicate human immune - tumor interactions for more predictive, ethical, and translatable preclinical outcomes.

Evotec’s humanized mice (huMice) platforms enable high-fidelity preclinical assessment of immunotherapies within a functional human immune system context. Whether leveraging rapid T-cell engraftment with HuPBMC models or comprehensive immune reconstitution through HuCD34+ models, our integrated solutions deliver the translational clarity needed to de-risk clinical development.

With state-of-the-art AAALAC-accredited facilities, expert immunologists, and in-depth PK/PD and biomarker analysis, Evotec empowers your immuno-oncology pipeline - from discovery to clinical readiness - with ethical, reproducible, and predictive data.